ZA200109966B - Apparatus for microporation of biological membranes using thin film tissue interface devices and method therefor - Google Patents
Apparatus for microporation of biological membranes using thin film tissue interface devices and method therefor Download PDFInfo
- Publication number
- ZA200109966B ZA200109966B ZA200109966A ZA200109966A ZA200109966B ZA 200109966 B ZA200109966 B ZA 200109966B ZA 200109966 A ZA200109966 A ZA 200109966A ZA 200109966 A ZA200109966 A ZA 200109966A ZA 200109966 B ZA200109966 B ZA 200109966B
- Authority
- ZA
- South Africa
- Prior art keywords
- biological membrane
- reservoir
- substance
- membrane
- skin
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 157
- 238000000034 method Methods 0.000 title claims abstract description 121
- 239000010409 thin film Substances 0.000 title claims description 13
- 239000000126 substance Substances 0.000 claims abstract description 84
- 230000004907 flux Effects 0.000 claims abstract description 66
- 239000000463 material Substances 0.000 claims description 77
- 239000010410 layer Substances 0.000 claims description 54
- 239000000758 substrate Substances 0.000 claims description 44
- 239000000853 adhesive Substances 0.000 claims description 42
- 230000001070 adhesive effect Effects 0.000 claims description 42
- 239000012530 fluid Substances 0.000 claims description 41
- 239000012491 analyte Substances 0.000 claims description 39
- 238000004519 manufacturing process Methods 0.000 claims description 39
- 150000001875 compounds Chemical class 0.000 claims description 30
- 239000000523 sample Substances 0.000 claims description 30
- 239000013060 biological fluid Substances 0.000 claims description 29
- 239000011159 matrix material Substances 0.000 claims description 27
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 26
- 239000003623 enhancer Substances 0.000 claims description 24
- 239000004020 conductor Substances 0.000 claims description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 16
- 238000004520 electroporation Methods 0.000 claims description 16
- 239000008103 glucose Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 14
- 229910001285 shape-memory alloy Inorganic materials 0.000 claims description 14
- 102000004877 Insulin Human genes 0.000 claims description 13
- 108090001061 Insulin Proteins 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 229940125396 insulin Drugs 0.000 claims description 13
- 230000037317 transdermal delivery Effects 0.000 claims description 12
- 239000013543 active substance Substances 0.000 claims description 9
- 239000012790 adhesive layer Substances 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 8
- 229960005486 vaccine Drugs 0.000 claims description 8
- 238000002679 ablation Methods 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- 230000008093 supporting effect Effects 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 238000005370 electroosmosis Methods 0.000 claims description 5
- 239000010408 film Substances 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 4
- 239000011888 foil Substances 0.000 claims description 4
- 238000000206 photolithography Methods 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 230000000975 bioactive effect Effects 0.000 claims description 3
- 238000005530 etching Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229940124583 pain medication Drugs 0.000 claims description 3
- 229940126585 therapeutic drug Drugs 0.000 claims description 3
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 2
- 230000000845 anti-microbial effect Effects 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 238000006073 displacement reaction Methods 0.000 claims description 2
- 230000002209 hydrophobic effect Effects 0.000 claims description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 230000032895 transmembrane transport Effects 0.000 claims description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 abstract description 20
- 241001465754 Metazoa Species 0.000 abstract description 11
- 230000001965 increasing effect Effects 0.000 abstract description 9
- 230000001976 improved effect Effects 0.000 abstract description 6
- 238000011282 treatment Methods 0.000 abstract description 4
- 238000003745 diagnosis Methods 0.000 abstract description 2
- 210000004379 membrane Anatomy 0.000 description 135
- 210000001519 tissue Anatomy 0.000 description 130
- 210000003491 skin Anatomy 0.000 description 114
- 239000011148 porous material Substances 0.000 description 53
- 210000004027 cell Anatomy 0.000 description 51
- 239000003814 drug Substances 0.000 description 45
- 230000008569 process Effects 0.000 description 45
- 229940079593 drug Drugs 0.000 description 44
- 210000000434 stratum corneum Anatomy 0.000 description 30
- 239000000306 component Substances 0.000 description 29
- 238000013461 design Methods 0.000 description 24
- 230000007246 mechanism Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 230000008901 benefit Effects 0.000 description 14
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 13
- 210000003722 extracellular fluid Anatomy 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 238000003556 assay Methods 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- 239000000976 ink Substances 0.000 description 10
- 229910052721 tungsten Inorganic materials 0.000 description 10
- 239000010937 tungsten Substances 0.000 description 10
- 230000004888 barrier function Effects 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 230000035699 permeability Effects 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 230000004913 activation Effects 0.000 description 8
- 238000007650 screen-printing Methods 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 238000004049 embossing Methods 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 238000003754 machining Methods 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000006835 compression Effects 0.000 description 6
- 238000007906 compression Methods 0.000 description 6
- 238000000151 deposition Methods 0.000 description 6
- 210000002615 epidermis Anatomy 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 229920000728 polyester Polymers 0.000 description 6
- 238000003825 pressing Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229910001080 W alloy Inorganic materials 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 description 5
- 229960001410 hydromorphone Drugs 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000005459 micromachining Methods 0.000 description 5
- 230000002572 peristaltic effect Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 229920001651 Cyanoacrylate Polymers 0.000 description 4
- 239000004830 Super Glue Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 238000012377 drug delivery Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- -1 permeants Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000004417 polycarbonate Substances 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 4
- 229910052715 tantalum Inorganic materials 0.000 description 4
- 239000002759 woven fabric Substances 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 206010033546 Pallor Diseases 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000000608 laser ablation Methods 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000003961 penetration enhancing agent Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 238000013271 transdermal drug delivery Methods 0.000 description 3
- 238000009834 vaporization Methods 0.000 description 3
- 230000008016 vaporization Effects 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 208000000003 Breakthrough pain Diseases 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108700012941 GNRH1 Proteins 0.000 description 2
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 229920001940 conductive polymer Polymers 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 210000004443 dendritic cell Anatomy 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000009713 electroplating Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 210000001821 langerhans cell Anatomy 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 229940127240 opiate Drugs 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000003319 supportive effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 239000000150 Sympathomimetic Substances 0.000 description 1
- 229910001362 Ta alloys Inorganic materials 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000002160 alpha blocker Substances 0.000 description 1
- 229940124308 alpha-adrenoreceptor antagonist Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 230000000578 anorexic effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002456 anti-arthritic effect Effects 0.000 description 1
- 230000001455 anti-clotting effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 229940035678 anti-parkinson drug Drugs 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 229940124346 antiarthritic agent Drugs 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940125708 antidiabetic agent Drugs 0.000 description 1
- 229940125714 antidiarrheal agent Drugs 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 229940124538 antidiuretic agent Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940005486 antimigraine preparations Drugs 0.000 description 1
- 239000002579 antinauseant Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000000164 antipsychotic agent Substances 0.000 description 1
- 229940005529 antipsychotics Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 238000007630 basic procedure Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000005219 brazing Methods 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 210000005178 buccal mucosa Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000004700 cellular uptake Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229940037530 cough and cold preparations Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 229940124581 decongestants Drugs 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 238000005474 detonation Methods 0.000 description 1
- AXZAYXJCENRGIM-UHFFFAOYSA-J dipotassium;tetrabromoplatinum(2-) Chemical compound [K+].[K+].[Br-].[Br-].[Br-].[Br-].[Pt+2] AXZAYXJCENRGIM-UHFFFAOYSA-J 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000010292 electrical insulation Methods 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 238000002847 impedance measurement Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 238000010309 melting process Methods 0.000 description 1
- IBIKHMZPHNKTHM-RDTXWAMCSA-N merck compound 25 Chemical compound C1C[C@@H](C(O)=O)[C@H](O)CN1C(C1=C(F)C=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 IBIKHMZPHNKTHM-RDTXWAMCSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000002445 parasympatholytic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000003450 potassium channel blocker Substances 0.000 description 1
- 229910001487 potassium perchlorate Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000003368 psychostimulant agent Substances 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000012945 sealing adhesive Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000005482 strain hardening Methods 0.000 description 1
- 210000000439 stratum lucidum Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000001975 sympathomimetic effect Effects 0.000 description 1
- 229940064707 sympathomimetics Drugs 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 239000011885 synergistic combination Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/20—Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
- A61B17/205—Vaccinating by means of needles or other puncturing devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0047—Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
- A61N1/0416—Anode and cathode
- A61N1/0424—Shape of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/044—Shape of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
- A61N1/306—Arrangements where at least part of the apparatus is introduced into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B2010/008—Interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00747—Dermatology
- A61B2017/00761—Removing layer of skin tissue, e.g. wrinkles, scars or cancerous tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- A61M2005/3022—Worn on the body, e.g. as patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0053—Methods for producing microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0452—Specially adapted for transcutaneous muscle stimulation [TMS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0476—Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13805099P | 1999-06-08 | 1999-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200109966B true ZA200109966B (en) | 2006-04-26 |
Family
ID=22480210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200109966A ZA200109966B (en) | 1999-06-08 | 2001-12-04 | Apparatus for microporation of biological membranes using thin film tissue interface devices and method therefor |
Country Status (14)
Country | Link |
---|---|
US (1) | US6692456B1 (fr) |
EP (4) | EP1189660B1 (fr) |
JP (3) | JP4412874B2 (fr) |
CN (1) | CN100402105C (fr) |
AT (1) | ATE324922T1 (fr) |
AU (1) | AU780752B2 (fr) |
CA (1) | CA2376368C (fr) |
CY (1) | CY1107518T1 (fr) |
DE (1) | DE60027720T2 (fr) |
DK (1) | DK1189660T3 (fr) |
ES (1) | ES2260021T3 (fr) |
PT (1) | PT1189660E (fr) |
WO (1) | WO2000074767A2 (fr) |
ZA (1) | ZA200109966B (fr) |
Families Citing this family (214)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6517532B1 (en) | 1997-05-15 | 2003-02-11 | Palomar Medical Technologies, Inc. | Light energy delivery head |
US20120150163A1 (en) * | 1997-08-12 | 2012-06-14 | Joseph Neev | Home Use Device and Method for Treating Skin Conditions |
PT1124607E (pt) | 1998-07-14 | 2008-12-31 | Altea Therapeutics Corp | Remoção controlada de membranas biológicas por carga pirotécnica, para transporte transmembranar |
US6148232A (en) | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
US6597946B2 (en) | 1998-11-09 | 2003-07-22 | Transpharma Ltd. | Electronic card for transdermal drug delivery and analyte extraction |
US6611706B2 (en) | 1998-11-09 | 2003-08-26 | Transpharma Ltd. | Monopolar and bipolar current application for transdermal drug delivery and analyte extraction |
US20030078499A1 (en) * | 1999-08-12 | 2003-04-24 | Eppstein Jonathan A. | Microporation of tissue for delivery of bioactive agents |
US20040005349A1 (en) * | 2000-05-12 | 2004-01-08 | Joseph Neev | Opto-thermal material modification |
AU2012201079B2 (en) * | 2000-06-01 | 2013-03-28 | Georgetown University | Systems and methods for monitoring health and delivering drugs transdermally |
GB0017999D0 (en) * | 2000-07-21 | 2000-09-13 | Smithkline Beecham Biolog | Novel device |
US20020115960A1 (en) * | 2000-08-24 | 2002-08-22 | Redding Bruce K. | Substance delivery system |
PL360998A1 (en) * | 2000-10-13 | 2004-09-20 | Alza Corporation | Apparatus and method for piercing skin with microprotrusions |
DE60124585T2 (de) * | 2000-12-28 | 2007-10-04 | Palomar Medical Technologies, Inc., Burlington | Apparat zur therapeutischen elektromagnetischen Strahlentherapie von der Haut |
DE10102817B4 (de) * | 2001-01-23 | 2006-01-12 | Lts Lohmann Therapie-Systeme Ag | Vorrichtung und Verfahren zur Hitzepulsgestützten transdermalen Applikation von Wirkstoffen |
IL158480A0 (en) * | 2001-04-20 | 2004-05-12 | Alza Corp | Microprojection array having a beneficial agent containing coating |
US6908448B2 (en) * | 2001-08-24 | 2005-06-21 | Dermisonics, Inc. | Substance delivery device |
AU2002330083A1 (en) * | 2001-09-21 | 2003-04-01 | Biovalve Technologies, Inc. | Gas pressure actuated microneedle arrays, and systems and methods relating to same |
CA2500453A1 (fr) * | 2001-09-28 | 2003-04-03 | Biovalve Technologies, Inc. | Micro-aiguille a membrane |
US6689100B2 (en) * | 2001-10-05 | 2004-02-10 | Becton, Dickinson And Company | Microdevice and method of delivering or withdrawing a substance through the skin of an animal |
US6648904B2 (en) * | 2001-11-29 | 2003-11-18 | Palomar Medical Technologies, Inc. | Method and apparatus for controlling the temperature of a surface |
EP1465529A4 (fr) * | 2002-01-15 | 2005-04-20 | Bruce K Redding Jr | Applicateur acoustique portatif et portable utilise pour induire la liberation de composes bioactifs par des organes internes |
US10022078B2 (en) * | 2004-07-13 | 2018-07-17 | Dexcom, Inc. | Analyte sensor |
US9918665B2 (en) | 2002-03-11 | 2018-03-20 | Nitto Denko Corporation | Transdermal porator and patch system and method for using same |
US8116860B2 (en) | 2002-03-11 | 2012-02-14 | Altea Therapeutics Corporation | Transdermal porator and patch system and method for using same |
ES2701884T3 (es) * | 2002-03-11 | 2019-02-26 | Nitto Denko Corp | Sistema de parche de administración transdérmica de fármacos |
AU2003226605A1 (en) * | 2002-04-19 | 2003-11-03 | Transpharma Medical Ltd. | Handheld transdermal drug delivery and analyte extraction |
CA2489506A1 (fr) | 2002-06-19 | 2003-12-31 | Palomar Medical Technologies, Inc. | Methode et appareil de traitement d'etats cutanes et sous-cutanes |
US7534241B2 (en) * | 2002-09-23 | 2009-05-19 | Microchips, Inc. | Micro-reservoir osmotic release systems and microtube array device |
US7399401B2 (en) | 2002-10-09 | 2008-07-15 | Abbott Diabetes Care, Inc. | Methods for use in assessing a flow condition of a fluid |
DK1552146T3 (da) * | 2002-10-09 | 2011-08-15 | Abbott Diabetes Care Inc | Anordning til indgivelse af fluid, system og fremgangsmåde |
US7431981B2 (en) * | 2002-11-04 | 2008-10-07 | The Boeing Company | Polymer composite structure reinforced with shape memory alloy and method of manufacturing same |
US20060184189A1 (en) † | 2002-11-15 | 2006-08-17 | Lorin Olson | Cap for a dermal tissue lancing device |
US20040225339A1 (en) * | 2002-12-20 | 2004-11-11 | Palomar Medical Technologies Inc. | Light treatments for acne and other disorders of follicles |
WO2004066903A2 (fr) * | 2003-01-29 | 2004-08-12 | E-Pill Pharma Ltd. | Apport de medicament actif dans le tube digestif |
US20040267240A1 (en) * | 2003-01-29 | 2004-12-30 | Yossi Gross | Active drug delivery in the gastrointestinal tract |
US20050058701A1 (en) * | 2003-01-29 | 2005-03-17 | Yossi Gross | Active drug delivery in the gastrointestinal tract |
US8323955B1 (en) * | 2003-03-05 | 2012-12-04 | Sandia Corporation | Micromachined patch-clamp apparatus |
EP1613202B1 (fr) * | 2003-03-27 | 2011-02-09 | The General Hospital Corporation | Appareil de traitement dermatologique et de restructuration fractionnelle de surface cutanee |
CA2820537C (fr) * | 2003-04-23 | 2015-10-20 | Valeritas, Inc. | Pompe activee hydrauliquement pour l'administration de fluide |
GB0312552D0 (en) * | 2003-06-02 | 2003-07-09 | Nel Technologies Ltd | Functional therapeutic corporeal and wound dressing heaters |
IL156374A0 (en) | 2003-06-10 | 2004-01-04 | Danenberg Holdings 2000 Ltd N | Method for removing a pigmented section of skin |
US20040267283A1 (en) | 2003-06-25 | 2004-12-30 | Daniela Mavor | Method, device and kit for body decoration |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
IL157696A0 (en) * | 2003-09-01 | 2004-03-28 | Hawk Medical Technologies Ltd | Apparatus and method for removing a pigmented section of skin |
US8016811B2 (en) * | 2003-10-24 | 2011-09-13 | Altea Therapeutics Corporation | Method for transdermal delivery of permeant substances |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
CN1886171A (zh) * | 2003-11-28 | 2006-12-27 | 艾克若克斯Dds有限公司 | 快速经皮施用的方法和系统 |
US20050228313A1 (en) * | 2003-12-04 | 2005-10-13 | University Technologies International Inc. | Fluid sampling, analysis and delivery system |
US20090069741A1 (en) * | 2004-04-09 | 2009-03-12 | Palomar Medical Technologies, Inc. | Methods And Devices For Fractional Ablation Of Tissue For Substance Delivery |
EP1748740A4 (fr) * | 2004-04-09 | 2008-12-31 | Palomar Medical Tech Inc | Procedes et traitement pour la production de reseaux d'ilots traites par rayonnement electromagnetique dans des tissus et leurs utilisations |
US8792955B2 (en) * | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9089636B2 (en) * | 2004-07-02 | 2015-07-28 | Valeritas, Inc. | Methods and devices for delivering GLP-1 and uses thereof |
US7654956B2 (en) | 2004-07-13 | 2010-02-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060024757A1 (en) * | 2004-07-30 | 2006-02-02 | Robert Hussa | Detection of oncofetal fibronectin for selection of concepti |
US7055756B2 (en) * | 2004-10-25 | 2006-06-06 | Lexmark International, Inc. | Deposition fabrication using inkjet technology |
US20060095001A1 (en) * | 2004-10-29 | 2006-05-04 | Transcutaneous Technologies Inc. | Electrode and iontophoresis device |
WO2006055729A1 (fr) * | 2004-11-16 | 2006-05-26 | Transcutaneous Technologies Inc. | Dispositif iontophoretique et procede pour adminstrer des agents ameliorant la reponse immunitaire et des compositions |
CA2591237A1 (fr) * | 2004-12-09 | 2006-06-15 | Flexible Medical Systems, Llc | Appareil et procede d'echantillonnage biomoleculaire, d'analyse et d'administration transdermique de traces en temps reel et en continu |
US7850645B2 (en) * | 2005-02-11 | 2010-12-14 | Boston Scientific Scimed, Inc. | Internal medical devices for delivery of therapeutic agent in conjunction with a source of electrical power |
US20060276859A1 (en) * | 2005-06-02 | 2006-12-07 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Photopatterning of skin |
US8157807B2 (en) * | 2005-06-02 | 2012-04-17 | The Invention Science Fund I, Llc | Skin treatment including patterned light |
EP1871457B1 (fr) * | 2005-04-11 | 2012-05-02 | Infotonics Technology Center, Inc. | Systemes et procedes pour le controle sanguin |
JP2006296511A (ja) * | 2005-04-15 | 2006-11-02 | Transcutaneous Technologies Inc | 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ |
WO2006111201A1 (fr) | 2005-04-18 | 2006-10-26 | Pantec Biosolutions Ag | Appareil laser de formation de micropores |
US7856985B2 (en) | 2005-04-22 | 2010-12-28 | Cynosure, Inc. | Method of treatment body tissue using a non-uniform laser beam |
CN101175529A (zh) * | 2005-05-19 | 2008-05-07 | 埃-皮尔制药公司 | 用于在组织中产生一氧化氮的可摄入装置 |
US20070032846A1 (en) * | 2005-08-05 | 2007-02-08 | Bran Ferren | Holographic tattoo |
JP2006334164A (ja) * | 2005-06-02 | 2006-12-14 | Transcutaneous Technologies Inc | イオントフォレーシス装置及びその制御方法 |
TWI419717B (zh) * | 2005-06-17 | 2013-12-21 | Altea Therapeutics Corp | 滲透傳送系統及其使用方法 |
AU2016231468B2 (en) * | 2005-06-17 | 2018-04-05 | Passport Technologies, Inc. | Permeant delivery system and methods for use thereof |
JP2006346368A (ja) * | 2005-06-20 | 2006-12-28 | Transcutaneous Technologies Inc | イオントフォレーシス装置及びその製造方法 |
US20070038270A1 (en) * | 2005-07-05 | 2007-02-15 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Multi step photopatterning of skin |
US20080214952A1 (en) * | 2005-07-11 | 2008-09-04 | Jose Mir | Replaceable Cartridge for Allergy Testing System |
US20090214625A1 (en) * | 2005-07-15 | 2009-08-27 | Mizuo Nakayama | Drug delivery patch |
BRPI0614477A2 (pt) * | 2005-08-01 | 2011-03-29 | Hawk Medical Technologies Ltd | uso de ácido salicìlico para a erradicação de pigmentação em uma área de pele, aparelho para essa erradicação e método de utilização de um aparelho para perfuração da pele |
US8295922B2 (en) * | 2005-08-08 | 2012-10-23 | Tti Ellebeau, Inc. | Iontophoresis device |
CN101282692A (zh) * | 2005-08-08 | 2008-10-08 | 帕洛玛医疗技术公司 | 人眼安全的光美容设备 |
US8386030B2 (en) * | 2005-08-08 | 2013-02-26 | Tti Ellebeau, Inc. | Iontophoresis device |
US20070060860A1 (en) * | 2005-08-18 | 2007-03-15 | Transcutaneous Technologies Inc. | Iontophoresis device |
WO2007026672A1 (fr) * | 2005-08-29 | 2007-03-08 | Transcu Ltd. | Composition d’électrolyte universelle pour l'ionophorèse |
US20070048340A1 (en) * | 2005-08-31 | 2007-03-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Multi step patterning of a skin surface |
CN101912288A (zh) * | 2005-09-02 | 2010-12-15 | 因特赛尔美国公司 | 经皮递送疫苗和透皮递送药物的装置及其应用 |
WO2007029611A1 (fr) * | 2005-09-06 | 2007-03-15 | Tti Ellebeau, Inc. | Dispositif d’iontophorèse |
US20070112294A1 (en) * | 2005-09-14 | 2007-05-17 | Transcutaneous Technologies Inc. | Iontophoresis device |
JPWO2007032446A1 (ja) | 2005-09-15 | 2009-03-19 | Tti・エルビュー株式会社 | ロッド型イオントフォレーシス装置 |
BRPI0616167A2 (pt) * | 2005-09-15 | 2011-06-07 | Palomar Medical Tech Inc | dispositivo de caracterização ótica da pele |
NZ566628A (en) * | 2005-09-16 | 2010-02-26 | Tti Ellebeau Inc | Catheter type iontophoresis apparatus using alternating layers of electrolytes and ion exchange membranes |
US20070071807A1 (en) * | 2005-09-28 | 2007-03-29 | Hidero Akiyama | Capsule-type drug-releasing device and capsule-type drug-releasing device system |
US20070078376A1 (en) * | 2005-09-30 | 2007-04-05 | Smith Gregory A | Functionalized microneedles transdermal drug delivery systems, devices, and methods |
KR20080066712A (ko) * | 2005-09-30 | 2008-07-16 | 티티아이 엘뷰 가부시키가이샤 | 관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법 |
US20070078445A1 (en) * | 2005-09-30 | 2007-04-05 | Curt Malloy | Synchronization apparatus and method for iontophoresis device to deliver active agents to biological interfaces |
WO2007041300A2 (fr) * | 2005-09-30 | 2007-04-12 | Tti Ellebeau, Inc. | Procede et appareil d'iontophorese pour l'administration systemique d'agents actifs |
JP2009509691A (ja) * | 2005-09-30 | 2009-03-12 | Tti・エルビュー株式会社 | 生体界面に多数の活性物質を送達するためのイオントフォレーシス装置 |
US20070232983A1 (en) * | 2005-09-30 | 2007-10-04 | Smith Gregory A | Handheld apparatus to deliver active agents to biological interfaces |
JP2009509659A (ja) * | 2005-09-30 | 2009-03-12 | Tti・エルビュー株式会社 | 生体界面への活性物質の送達のイオントフォレーシス装置及び方法 |
US20070135754A1 (en) * | 2005-09-30 | 2007-06-14 | Hidero Akiyama | Electrode assembly for iontophoresis for administering active agent enclosed in nanoparticle and iontophoresis device using the same |
WO2007041322A2 (fr) * | 2005-09-30 | 2007-04-12 | Tti Ellebeau, Inc. | Apport ionophoretique d'agents actifs conjugues a des nanoparticules |
US7574256B2 (en) * | 2005-09-30 | 2009-08-11 | Tti Ellebeau, Inc. | Iontophoretic device and method of delivery of active agents to biological interface |
US8372806B2 (en) | 2005-10-06 | 2013-02-12 | Pantec Biosolutions Ag | Transdermal delivery system for treating infertility |
US20070197955A1 (en) * | 2005-10-12 | 2007-08-23 | Transcutaneous Technologies Inc. | Mucous membrane adhesion-type iontophoresis device |
CN101331392B (zh) * | 2005-11-02 | 2012-08-08 | 梅-鲁宾科技公司 | 用于产生电场的高阻抗系统及所使用的方法 |
US8226811B2 (en) * | 2005-11-02 | 2012-07-24 | May-Ruben Technologies, Inc. | High impedance system for generating electric fields and method of use |
US7963917B2 (en) * | 2005-12-05 | 2011-06-21 | Echo Therapeutics, Inc. | System and method for continuous non-invasive glucose monitoring |
WO2007079116A1 (fr) * | 2005-12-28 | 2007-07-12 | Tti Ellebeau, Inc. | Appareil de pompe électroosmotique et procédé pour acheminer des agents actifs à des interfaces biologiques |
WO2007079190A2 (fr) * | 2005-12-29 | 2007-07-12 | Tti Ellebeau, Inc. | Dispositif et procede renforçant la reponse immunitaire par stimulation electrique |
EP1965858A2 (fr) * | 2005-12-30 | 2008-09-10 | Tti Ellebeau, Inc. | Système et procédé de commande à distance d'un dispositif d'iontophorèse |
JP2009522011A (ja) * | 2005-12-30 | 2009-06-11 | Tti・エルビュー株式会社 | 活性物質を生体界面に送達するイオントフォレーシスシステム、装置及び方法 |
ATE532553T1 (de) | 2006-02-10 | 2011-11-15 | Hisamitsu Pharmaceutical Co | Transdermales arzneiverabreichungsgerät mit mikronadeln |
ES2566058T3 (es) | 2006-03-30 | 2016-04-08 | Valeritas, Inc. | Dispositivo de suministro de fluidos de múltiples cartuchos |
WO2007123707A1 (fr) * | 2006-03-30 | 2007-11-01 | Tti Ellebeau, Inc. | Membrane à libération contrôlée et ses procédés d'utilisation |
US20080234626A1 (en) * | 2006-04-26 | 2008-09-25 | Chelak Todd M | Multi-stage microporation device |
WO2008010905A2 (fr) * | 2006-06-30 | 2008-01-24 | Cvdevices, Llc | Accès intravasculaire percutané au tissu cardiaque |
KR20090027755A (ko) * | 2006-07-05 | 2009-03-17 | 티티아이 엘뷰 가부시키가이샤 | 자기-조립형 수지상 중합체를 함유하는 전달 장치 및 이의 사용 방법 |
US20100100005A1 (en) * | 2006-07-11 | 2010-04-22 | Infotonics Technology Center, Inc. | Minimally invasive allergy testing system with coated allergens |
US7586957B2 (en) | 2006-08-02 | 2009-09-08 | Cynosure, Inc | Picosecond laser apparatus and methods for its operation and use |
US20080077076A1 (en) * | 2006-08-29 | 2008-03-27 | Transcutaneous Technologies Inc. | Iontophoresis device and method for operation with a usb (universal serial bus) power source |
US7720622B2 (en) * | 2006-09-05 | 2010-05-18 | Tti Ellebeau, Inc. | Non-destructive systems, devices, and methods for evaluating iontophoresis drug delivery devices |
WO2008030497A2 (fr) * | 2006-09-05 | 2008-03-13 | Tti Ellebeau, Inc. | Système d'administration transdermique de médicaments par des alimentations en courant inductif |
CN101541375A (zh) * | 2006-09-05 | 2009-09-23 | Tti优而美株式会社 | 用于评价化合物的离子电渗性质的阻抗系统、装置和方法 |
WO2008029403A1 (fr) * | 2006-09-06 | 2008-03-13 | Medingo Ltd. | Système de délivrance de fluides à détection optique du niveau de concentration d'analytes |
US20100004582A1 (en) * | 2006-10-25 | 2010-01-07 | Pantec Biosolutions Ag | Wide-Area Parasystemic Treatment of Skin Related Conditions |
US7842006B2 (en) * | 2006-11-17 | 2010-11-30 | Cfd Research Corporation | Thrombectomy microcatheter |
US8062783B2 (en) | 2006-12-01 | 2011-11-22 | Tti Ellebeau, Inc. | Systems, devices, and methods for powering and/or controlling devices, for instance transdermal delivery devices |
US20080152592A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of therapeutic drug monitoring |
WO2008083305A2 (fr) * | 2006-12-29 | 2008-07-10 | Palomar Medical Technologies, Inc. | Procédés et dispositifs permettant une ablation fractionnelle d'un tissu |
WO2008087884A1 (fr) * | 2007-01-16 | 2008-07-24 | Tti Ellebeau, Inc. | Procédé et logiciel de prédiction de dose de médicament |
CA2925191C (fr) | 2007-01-22 | 2018-07-24 | Nitto Denko Corporation | Systeme de formation de pores et de timbre transdermique et procede d'utilisation correspondant |
US7713196B2 (en) * | 2007-03-09 | 2010-05-11 | Nellcor Puritan Bennett Llc | Method for evaluating skin hydration and fluid compartmentalization |
US20080228056A1 (en) | 2007-03-13 | 2008-09-18 | Michael Blomquist | Basal rate testing using frequent blood glucose input |
US20100210932A1 (en) * | 2007-03-20 | 2010-08-19 | Bayer Healthcare Llc | Method of analyzing an analyte |
EP2139549A1 (fr) | 2007-03-29 | 2010-01-06 | Cupola Medical Ltd | Dispositif et système pour le traitement de la peau |
NZ582049A (en) * | 2007-05-18 | 2012-12-21 | Tti Ellebeau Inc | Transdermal delivery devices assuring an improved release of an active principle through a biological interface |
US7751907B2 (en) | 2007-05-24 | 2010-07-06 | Smiths Medical Asd, Inc. | Expert system for insulin pump therapy |
US8221345B2 (en) | 2007-05-30 | 2012-07-17 | Smiths Medical Asd, Inc. | Insulin pump based expert system |
JP2010187707A (ja) * | 2007-06-12 | 2010-09-02 | Hokkaido Univ | インスリンを封入したイオントフォレーシス用リポソーム製剤 |
US20090012446A1 (en) * | 2007-07-03 | 2009-01-08 | Xinyan Cui | Devices, systems and methods for release of chemical agents |
US8328720B2 (en) * | 2007-08-10 | 2012-12-11 | Infotonics Technology Center, Inc. | MEMS interstitial prothrombin time test |
EP2200666B1 (fr) | 2007-10-09 | 2014-12-03 | Syneron Medical Ltd. | Fixation magnétique d'un timbre transdermique |
EP2205967B1 (fr) * | 2007-10-17 | 2013-05-01 | Syneron Medical Ltd. | Vérification de la vitesse de dissolution |
US8500697B2 (en) * | 2007-10-19 | 2013-08-06 | Pressure Products Medical Supplies, Inc. | Transseptal guidewire |
WO2009052866A1 (fr) * | 2007-10-25 | 2009-04-30 | Pantec Biosolutions Ag | Dispositif laser et procédé pour une ablation de tissu biologique |
CA2704164A1 (fr) * | 2007-10-29 | 2009-05-07 | Transpharma Medical Ltd. | Sechage vertical de timbres transdermiques |
AU2008332738B2 (en) | 2007-12-05 | 2013-08-15 | Syneron Medical Ltd. | A disposable electromagnetic energy applicator and method of using it |
CN101970030B (zh) | 2007-12-17 | 2014-04-16 | 新世界药品有限公司 | 整合的真皮内递送、诊断和通讯系统 |
US7963947B2 (en) * | 2008-01-16 | 2011-06-21 | Pressure Products Medical Supplies, Inc. | Apparatus, system, and method of shielding the sharp tip of a transseptal guidewire |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
NZ604092A (en) * | 2008-03-31 | 2015-08-28 | Nitto Denko Corp | Permeant delivery system and methods for use thereof |
WO2009148613A1 (fr) * | 2008-06-04 | 2009-12-10 | Coda Therapeutics, Inc. | Traitement de la douleur avec des composés de modulation de jonction communicante |
US8834446B2 (en) * | 2008-06-12 | 2014-09-16 | DePuy Synthes Products, LLC | Pulsatile flux drug delivery |
DE102008002520A1 (de) * | 2008-06-19 | 2009-12-24 | Robert Bosch Gmbh | Vorrichtung zur Bestimmung und/oder Überwachung des Flüssigkeitsgehalts der Haut |
US8996104B2 (en) * | 2008-06-25 | 2015-03-31 | Fe3 Medical, Inc. | Patches and method for the transdermal delivery of a therapeutically effective amount of iron |
US8404255B2 (en) * | 2008-07-29 | 2013-03-26 | Matt Gibson | System and method for transdermal drug delivery |
CA2964564C (fr) * | 2008-08-21 | 2019-10-22 | Ninepoint Medical, Inc. | Dispositif d'evaluation de medicament et de traitement local |
AR073575A1 (es) * | 2008-09-10 | 2010-11-17 | Transcu Ltd | Aparato y metodo para dispensar basados en hpc liquidos viscosos en sustratos porosos por ejemplo proceso continuo basado en bandas |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
CA2737461A1 (fr) | 2008-09-19 | 2010-03-25 | Tandem Diabetes Care, Inc. | Dispositif de mesure de la concentration d'un solute et procedes associes |
US8606366B2 (en) | 2009-02-18 | 2013-12-10 | Syneron Medical Ltd. | Skin treatment apparatus for personal use and method for using same |
US8617487B2 (en) | 2009-03-25 | 2013-12-31 | Venture Lending & Leasing Vi, Inc. | Saliva sample collection systems |
US8821945B2 (en) * | 2009-04-25 | 2014-09-02 | Fe3 Medical, Inc. | Method for transdermal iontophoretic delivery of chelated agents |
US20110066175A1 (en) * | 2009-05-07 | 2011-03-17 | Rainbow Medical Ltd. | Gastric anchor |
US8414559B2 (en) * | 2009-05-07 | 2013-04-09 | Rainbow Medical Ltd. | Gastroretentive duodenal pill |
US20100286628A1 (en) * | 2009-05-07 | 2010-11-11 | Rainbow Medical Ltd | Gastric anchor |
US20100286587A1 (en) * | 2009-05-07 | 2010-11-11 | Yossi Gross | Sublingual electrical drug delivery |
US20100312168A1 (en) * | 2009-06-09 | 2010-12-09 | Yoshimasa Yoshida | Long life high capacity electrode, device, and method of manufacture |
US9919168B2 (en) | 2009-07-23 | 2018-03-20 | Palomar Medical Technologies, Inc. | Method for improvement of cellulite appearance |
EP2459251B1 (fr) | 2009-07-30 | 2014-03-12 | Tandem Diabetes Care, Inc. | Système de pompe de perfusion à cartouche jetable comprenant une décharge de pression et une rétroaction de pression |
JP5406646B2 (ja) * | 2009-09-16 | 2014-02-05 | シスメックス株式会社 | 組織液収集方法に用いる組織液収集キット及び組織液収集シート |
CN102724913A (zh) | 2009-09-30 | 2012-10-10 | 德克斯康公司 | 经皮分析物传感器 |
SG170622A1 (en) * | 2009-10-09 | 2011-05-30 | Nitto Denko Corp | A passive drug delivery device and a method of drug delivery |
FR2955024B1 (fr) * | 2010-01-14 | 2012-02-10 | Commissariat Energie Atomique | Dispositif de mise en contact transitoire d'au moins une unite de capture de cibles biologiques avec un fluide les contenant, et procede de recuperation des cibles capturees |
IL295704B2 (en) | 2010-03-03 | 2023-11-01 | Lumenis Be Ltd | Equipment and methods for tissue microbibilization using fractional treatment patterns |
WO2011115328A1 (fr) * | 2010-03-16 | 2011-09-22 | 서울대학교 산학협력단 | Système d'administration de médicament par microjet |
US9327105B2 (en) | 2010-03-26 | 2016-05-03 | Itrace Biomedical Inc. | Active transdermal drug delivery system and the method thereof |
US9604039B2 (en) * | 2010-06-18 | 2017-03-28 | The Regents Of The University Of California | Unobstructing microdevices for self-clearing implantable catheters |
US8936825B2 (en) * | 2010-09-23 | 2015-01-20 | Monosol Rx, Llc | Method and system for forming a pharmaceutical product directly onto a packaging surface |
EP2438938A1 (fr) * | 2010-10-11 | 2012-04-11 | PharmaSens AG | Pompe de type seringue |
US10707570B1 (en) * | 2010-11-22 | 2020-07-07 | Ncap Licensing, Llc | Techniques for pain relief |
US10244981B2 (en) * | 2011-03-30 | 2019-04-02 | SensiVida Medical Technologies, Inc. | Skin test image analysis apparatuses and methods thereof |
US20140303546A1 (en) * | 2011-06-24 | 2014-10-09 | University Of Miami | Laser assisted delivery of functional cells, peptides and nucleotides |
US9700245B2 (en) * | 2011-09-23 | 2017-07-11 | Itrace Biomedical Inc. | Transdermal analyte extraction and detection system and the method thereof |
US20150005595A1 (en) | 2011-12-30 | 2015-01-01 | Kibur Medical, Inc. | Implantable devices and methods for evaluation of active agents |
JP6563653B2 (ja) | 2011-12-30 | 2019-08-21 | カイバー メディカル, インコーポレイテッド | 活性薬剤を評価するための移植可能なデバイスおよび方法 |
WO2013148736A1 (fr) | 2012-03-27 | 2013-10-03 | Coda Therapeutics, Inc. | Compositions et traitements basés sur la modulation de la cadhérine |
WO2013158299A1 (fr) | 2012-04-18 | 2013-10-24 | Cynosure, Inc. | Appareil à laser picoseconde et procédé de traitement de tissus cibles à l'aide de celui-ci |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
CA2873881A1 (fr) | 2012-05-18 | 2013-11-21 | Stephen Bruce Fleming | Traitements combines et compositions pour la cicatrisation de plaies |
US20140213866A1 (en) | 2012-10-12 | 2014-07-31 | Dexcom, Inc. | Sensors for continuous analyte monitoring, and related methods |
TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
US9710607B2 (en) | 2013-01-15 | 2017-07-18 | Itrace Biomedical Inc. | Portable electronic therapy device and the method thereof |
US10179239B2 (en) | 2013-01-15 | 2019-01-15 | Itrace Biomedical Inc. | Personalized pain management treatments |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US10285757B2 (en) | 2013-03-15 | 2019-05-14 | Cynosure, Llc | Picosecond optical radiation systems and methods of use |
US9603995B2 (en) | 2013-03-15 | 2017-03-28 | Tandem Diabetes Care. Inc. | Device and method for setting therapeutic parameters for an infusion device |
BR112015032929B1 (pt) * | 2013-07-03 | 2022-08-23 | Lts Lohmann Therapie-Systeme Ag | Sistema terapêutico transdérmico com componente eletrônico e métodos de produção de um sistema terapêutico transdérmico |
US10413359B2 (en) * | 2013-07-18 | 2019-09-17 | International Business Machines Corporation | Laser-assisted transdermal delivery of nanoparticulates and hydrogels |
US9341639B2 (en) | 2013-07-26 | 2016-05-17 | Industrial Technology Research Institute | Apparatus for microfluid detection |
US20150289788A1 (en) | 2014-04-10 | 2015-10-15 | Dexcom, Inc. | Sensors for continuous analyte monitoring, and related methods |
CN106456566B (zh) | 2014-05-20 | 2020-06-16 | Lts勒曼治疗系统股份公司 | 含罗替戈汀的经皮递送系统 |
US11752110B2 (en) | 2014-05-20 | 2023-09-12 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system including an interface mediator |
CN106456567A (zh) | 2014-05-20 | 2017-02-22 | Lts勒曼治疗系统股份公司 | 在经皮递送系统中调节活性剂释放的方法 |
MX2017014581A (es) | 2015-05-15 | 2018-03-09 | Clearit Llc | Sistemas y metodos para eliminacion de tatuajes utilizando plasma frio. |
US20200324099A1 (en) * | 2016-04-06 | 2020-10-15 | Mupharma Pty Ltd | Acoustic wave mediated non-invasive drug delivery |
EP3338853A1 (fr) | 2016-12-23 | 2018-06-27 | Sanofi-Aventis Deutschland GmbH | Dispositifs d'administration de médicaments |
JP6842059B2 (ja) * | 2017-01-11 | 2021-03-17 | 帝人フロンティア株式会社 | 圧電構造体及びそれを用いたデバイス |
EP3609686A4 (fr) | 2017-04-12 | 2020-09-09 | The Government of the United States of America, as represented by the Secretary of the Navy | Substrat d'électrofilage à température régulée |
ES2885062T3 (es) * | 2017-06-28 | 2021-12-13 | Fundacion Tecnalia Res & Innovation | Dispositivo para la administración transdérmica controlada y vigilada de principios activos y uso del mismo |
KR102627248B1 (ko) | 2018-02-26 | 2024-01-19 | 싸이노슈어, 엘엘씨 | Q-스위치드 캐비티 덤핑 서브 나노초 레이저 |
SG11202109440RA (en) * | 2018-05-30 | 2021-09-29 | Tze Guan Ong | Non-invasive transportation method |
DE102018215324A1 (de) * | 2018-09-10 | 2020-03-12 | Lts Lohmann Therapie-Systeme Ag | Vorrichtung und Verfahren zur Herstellung von Mikrostrukturen |
KR20210104780A (ko) | 2018-12-19 | 2021-08-25 | 클리어잇 엘엘씨 | 인가된 전계를 사용한 문신 제거 시스템들 및 방법들 |
US11969576B2 (en) | 2019-07-03 | 2024-04-30 | Tandem Diabetes Care, Inc. | Methods of incorporating CGM data into diabetes therapy |
CN110664439B (zh) * | 2019-09-05 | 2021-07-27 | 华中科技大学 | 一种可提取皮肤组织液的微针及其制备方法 |
US11654236B2 (en) | 2019-11-22 | 2023-05-23 | Tandem Diabetes Care, Inc. | Systems and methods for automated insulin delivery for diabetes therapy |
WO2024080052A1 (fr) * | 2022-10-12 | 2024-04-18 | ヤーマン株式会社 | Dispositif de traitement de la peau et feuille électroconductrice |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5224928A (en) * | 1983-08-18 | 1993-07-06 | Drug Delivery Systems Inc. | Mounting system for transdermal drug applicator |
US4775361A (en) | 1986-04-10 | 1988-10-04 | The General Hospital Corporation | Controlled removal of human stratum corneum by pulsed laser to enhance percutaneous transport |
US5380272A (en) * | 1993-01-28 | 1995-01-10 | Scientific Innovations Ltd. | Transcutaneous drug delivery applicator |
US5885211A (en) * | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
JPH10509632A (ja) * | 1995-07-25 | 1998-09-22 | マサチューセッツ インスティチュート オブ テクノロジー | 超音波を使用する増強された経皮送達 |
PT1563788E (pt) | 1995-08-29 | 2015-06-02 | Nitto Denko Corp | Microporação de pele humana para distribuição de fármaco e aplicações de monitorização |
WO1998000194A2 (fr) * | 1996-06-28 | 1998-01-08 | Sontra Medical, L.P. | Amelioration du transport transdermique par ultrason |
DK0921840T3 (da) * | 1996-07-03 | 2003-09-22 | Altea Therapeutics Corp | Multipel mekanisk mikroperforering af hud eller slimhinde |
DE69720057T2 (de) * | 1996-12-20 | 2003-09-25 | Alza Corp | Vorrichtung und verfahren zur erhöhung des transdermalen wirkstoffeflusses |
CA2789115C (fr) | 1996-12-31 | 2014-04-29 | Altea Therapeutics Corporation | Formation de micropores sur un tissu pour l'administration d'agents bioactifs |
WO1999029364A1 (fr) | 1997-12-11 | 1999-06-17 | Alza Corporation | Dispositif renforçant le flux d'agents transdermiques |
ATE302041T1 (de) * | 1997-12-11 | 2005-09-15 | Alza Corp | Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses |
ATE375752T1 (de) | 1998-03-06 | 2007-11-15 | Spectrx Inc | Integrierte gewebeporations-, flüssigkeitsammel- und analysevorrichtung |
US6173202B1 (en) * | 1998-03-06 | 2001-01-09 | Spectrx, Inc. | Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
US6022316A (en) * | 1998-03-06 | 2000-02-08 | Spectrx, Inc. | Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications |
PT1124607E (pt) | 1998-07-14 | 2008-12-31 | Altea Therapeutics Corp | Remoção controlada de membranas biológicas por carga pirotécnica, para transporte transmembranar |
WO2000004821A1 (fr) | 1998-07-21 | 2000-02-03 | Spectrx, Inc. | Traitement du fluide dans un dispositif de prelevement et de detection en continu de fluide |
AU5004299A (en) | 1998-07-21 | 2000-02-14 | Altea Technologies, Inc. | System and method for continuous analyte monitoring |
EP1112021A1 (fr) | 1998-09-10 | 2001-07-04 | Spectrx, Inc. | Correction d'attributs pour la detection et/ou la surveillance continue d'analytes |
US6148232A (en) * | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
US6251083B1 (en) * | 1999-09-07 | 2001-06-26 | Amira Medical | Interstitial fluid methods and devices for determination of an analyte in the body |
-
2000
- 2000-06-08 AT AT00939765T patent/ATE324922T1/de active
- 2000-06-08 ES ES00939765T patent/ES2260021T3/es not_active Expired - Lifetime
- 2000-06-08 WO PCT/US2000/015979 patent/WO2000074767A2/fr active IP Right Grant
- 2000-06-08 CN CNB008105146A patent/CN100402105C/zh not_active Expired - Lifetime
- 2000-06-08 JP JP2001501298A patent/JP4412874B2/ja not_active Expired - Lifetime
- 2000-06-08 US US09/590,787 patent/US6692456B1/en not_active Expired - Lifetime
- 2000-06-08 DE DE60027720T patent/DE60027720T2/de not_active Expired - Lifetime
- 2000-06-08 EP EP00939765A patent/EP1189660B1/fr not_active Expired - Lifetime
- 2000-06-08 DK DK00939765T patent/DK1189660T3/da active
- 2000-06-08 PT PT00939765T patent/PT1189660E/pt unknown
- 2000-06-08 EP EP09015859A patent/EP2168497A3/fr not_active Withdrawn
- 2000-06-08 AU AU54799/00A patent/AU780752B2/en not_active Ceased
- 2000-06-08 EP EP10012388A patent/EP2286868A3/fr not_active Withdrawn
- 2000-06-08 EP EP05028332A patent/EP1645305A1/fr not_active Withdrawn
- 2000-06-08 CA CA002376368A patent/CA2376368C/fr not_active Expired - Lifetime
-
2001
- 2001-12-04 ZA ZA200109966A patent/ZA200109966B/en unknown
-
2006
- 2006-07-21 CY CY20061101018T patent/CY1107518T1/el unknown
-
2009
- 2009-02-24 JP JP2009041516A patent/JP2009148588A/ja not_active Withdrawn
-
2010
- 2010-03-29 JP JP2010076330A patent/JP5460419B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE324922T1 (de) | 2006-06-15 |
EP1189660A2 (fr) | 2002-03-27 |
EP2286868A2 (fr) | 2011-02-23 |
EP2168497A3 (fr) | 2010-12-01 |
EP1189660B1 (fr) | 2006-05-03 |
JP5460419B2 (ja) | 2014-04-02 |
ES2260021T3 (es) | 2006-11-01 |
EP2286868A3 (fr) | 2012-05-16 |
DK1189660T3 (da) | 2006-08-21 |
DE60027720T2 (de) | 2007-04-26 |
WO2000074767A3 (fr) | 2001-07-05 |
CA2376368A1 (fr) | 2000-12-14 |
DE60027720D1 (de) | 2006-06-08 |
US6692456B1 (en) | 2004-02-17 |
EP1645305A1 (fr) | 2006-04-12 |
EP2168497A2 (fr) | 2010-03-31 |
AU5479900A (en) | 2000-12-28 |
CY1107518T1 (el) | 2013-03-13 |
CN1420795A (zh) | 2003-05-28 |
JP4412874B2 (ja) | 2010-02-10 |
CA2376368C (fr) | 2009-08-11 |
JP2004505652A (ja) | 2004-02-26 |
PT1189660E (pt) | 2006-09-29 |
JP2009148588A (ja) | 2009-07-09 |
AU780752B2 (en) | 2005-04-14 |
JP2010158554A (ja) | 2010-07-22 |
WO2000074767A2 (fr) | 2000-12-14 |
CN100402105C (zh) | 2008-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2376368C (fr) | Appareil pour creer des micropores dans des membranes biologiques a l'aide d'interfaces de tissus minces, et procede associe | |
US9486616B2 (en) | Transdermal integrated actuator device, methods of making and using same | |
AU4996499A (en) | Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport |